-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Post-stroke delirium (PSD) is an independent predictor of a patient's poor prognostication.
although their individual and socio-economic burden, frequency of occurrence, clinical course and routine testing are not yet clear.
recently published a study in the authoritative journal Stroke on Cardiovascular Disease, which aims to assess the properties of known delirium screening tools and investigate the natural course of PSD.
study looked at patients with high-risk transient ischemic episodes or ischemic stroke over a three-month period.
researchers used delirium care scales and delirium rapid assessment methods to conduct two PSD screenings per day and to conduct non-poor evaluations with the standards of the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders.
researchers investigated demographic and stroke characteristics as predictors of PSD, neurological dysfunction as predictors of false positive screening results, and conducted simulation studies to estimate the best time to identify PSD.
the researchers included 141 patients (73.8±10.4 years of age, 61 women), with the National Institutes of Health's stroke scale scoring an average of 6.4±6.5.
PSD, based on the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders, was 39 per cent, with 25 per cent of cases occurring within 24 hours and almost all within 72 hours.
assessment method is the only screening tool that is no less than the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders, with sensitivity of 82 per cent and specificity of 80 per cent.
(ratio of 1.07 (1.02-1.13), P=0.004) and the National Institutes of Health stroke scale (ratio of 1.24 (1.15-1.34), P<0.001) are predictive factors for PSD.
false positive screening results were associated with directional disorders caused by stroke (ratio of 6.1 (3.2-11.61), P <0.001) and indifference (ratio of 2.17 (1.22-3.87) and P=0.008).
simulations show that one out of every four cases is missed.
, PSD is a common complication of stroke and transient ischemic episodes.
detection of PSD is challenged by mixed effects such as hypoctopic neurological deficiencies and the need for at least daily screening.
